Zobrazeno 1 - 10
of 290
pro vyhledávání: '"Camil Fuchs"'
Autor:
Mason, Robert L.
Publikováno v:
Technometrics, 1999 May 01. 41(2), 168-169.
Externí odkaz:
https://www.jstor.org/stable/1270734
Publikováno v:
Journal of Data Science. 8:645-664
Lifetime morbid risks are usually determined either by the Kaplan- Meier product limit estimator or by simpler estimators such as the lifetime prevalence, the Weinberg method or the Schulz method, which can be con- sidered an elaboration of the Weinb
Autor:
Rodman, David1 djrodman@optimum.net
Publikováno v:
Israel Affairs. Aug2020, Vol. 26 Issue 4, p614-615. 2p.
Publikováno v:
Comparative Perspectives on Racism ISBN: 9781315196374
Comparative Perspectives on Racism
Comparative Perspectives on Racism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::767807edc80ff8d15799bf6bfa19c164
https://doi.org/10.4324/9781315196374-10
https://doi.org/10.4324/9781315196374-10
Elevated rate of OCD-spectrum and tic disorders in patients with bipolar depression and comorbid OCD
Publikováno v:
Journal of Obsessive-Compulsive and Related Disorders. 29:100643
Objectives To evaluate whether patients with bipolar depression (BP-D) and comorbid obsessive-compulsive disorder (OCD) have predominant aggregation of additional OCD-spectrum and tic disorders compared to their “pure” BP-D counterparts. Methods
Autor:
Yair Klieger, Inna Varfolomeev, Moshe Sade-Feldman, Ilan Vaknin, Camil Fuchs, Roy Eldor, Michal Baniyash
Publikováno v:
Diabetes Care. 38:113-118
OBJECTIVE We have previously shown that chronic inflammation results in immunosuppression associated with CD247 downregulation in T lymphocytes. Type 2 diabetes mellitus (T2DM) is known to be associated with chronic inflammation. We therefore sought
Autor:
Irit Gil-Ad, Avi Amrami-Weizman, Michael Poyurovsky, Artashez Pashinian, Camil Fuchs, Rachel Maayan, Moshe Kotler
Publikováno v:
Psychopharmacology. 230:23-27
We previously demonstrated that the addition of the selective norepinephrine reuptake inhibitor reboxetine attenuates olanzapine-induced weight gain. Using the same study sample, we also sought to determine whether reboxetine's weight-attenuating eff
Autor:
Michael Poyurovsky, Abraham Weizman, Ronit Weizman, Adva Levi, Camil Fuchs, Artashez Pashinian
Publikováno v:
Psychopharmacology. 226:615-622
Combination treatment with reboxetine, a selective norepinephrine reuptake inhibitor, and betahistine, a histamine H1 receptor agonist/H3 antagonist, was developed to produce complementary action in CNS pathways regulating appetite and body weight. I
Autor:
Inbari, Motti1 (AUTHOR) inbari@uncp.edu, Bumin, Kirill M.2 (AUTHOR) inbari@uncp.edu
Publikováno v:
Religions. Sep2024, Vol. 15 Issue 9, p1076. 22p.
Autor:
Artashez Pashinian, Michael Poyurovsky, Vered Kleinman-Balush, Camil Fuchs, Sarit Faragian, Rena Kurs
Publikováno v:
Journal of Nervous & Mental Disease. 195:765-768
Obsessive-compulsive symptoms (OCS) have been revealed in a substantial proportion of schizophrenia patients. We sought to evaluate insight into OCS in schizo-obsessive patients. We evaluated insight into OCS and awareness of schizophrenia, using the